Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2014-03-27 Regulatory Filings
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Change in substantial holding 2 pages 226.9KB
Regulatory Filings
2014-03-27 English
Appendix 3B shares to be issued under Rights Issue 12 pages 501.1KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. It includes detailed information about the class and number of securities issued, issue price, purpose of the issue, shareholder approvals, and quotation agreements. The document does not contain financial statements, management discussion, or earnings data. It is a regulatory announcement about a capital raising event and securities issuance, not a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed issuance information, supporting a high confidence in classification.
2014-03-27 English
Completion of Rights Issue and Notice of shortfall 2 pages 237.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 28 March 2014 regarding the close of a Rights Issue Entitlement Offer and notice of shortfall. It details the number of shares accepted, the shortfall, allotment dates, and trading commencement. It also discusses the company's plans and mentions the joint lead managers. The document is focused on fundraising activity and capital structure changes related to a rights issue. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. The content fits the definition of a Capital/Financing Update (CAP). The document length is under 5,000 characters and is a direct announcement, not a report publication notice or certification. Therefore, the correct classification is CAP with high confidence.
2014-03-27 English
Change of Director's Interest Notice 2 pages 215.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the interest, and transaction details. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3544 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2014-03-26 English
Amended Change of Director's Interest Notice 2 pages 215.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the interest, and transaction details. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, management discussion, or other report types. Therefore, it fits the definition of Director's Dealing (DIRS). The document length is 3518 characters, consistent with a detailed notice but not a full report or announcement of a report. Confidence is high due to clear identification of director share transactions and regulatory references specific to director dealings.
2014-03-26 English
Change in substantial holding 2 pages 995.7KB
Regulatory Filings
2014-03-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.